Mylan Pharmaceuticals Inc. et al. vs. Novo Nordisk A/S
Explore the PTAB proceeding IPR2023-00722 filed by Mylan Pharmaceuticals Inc. et al. on 2023-03-16. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2023-00722
Filing Date
2023-03-16
Accorded Filing Date
2023-03-16
Institution Decision Date
2023-10-02
Last Modified Date
2023-12-22
Proceeding Type
IPR
Termination Date
2023-10-02
Trial Status
Institution Denied
Parties & Counsel
Petitioner
Mylan Pharmaceuticals Inc. et al.
Represented By
White, Brandonet alPatent Owner / Respondent
Novo Nordisk A/S
Represented By
Baughman, Jonet alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
1 Total
Proceeding Status
Institution Denied
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (1)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 56129 | Wesley Nicolas | +1 609-786-5418 |
| 62124 | Leon Lum | +1 609-786-4172 |
| 63996 | Elizabeth Dingess-Hammond | +1 317-433-3689 |
| 64519 | Jianjie Hu | +1 609-786-4129 |
| 74995 | Kathryn Jones | +1 804-426-7196 |
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 5 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 8,536,122 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| 🇪🇺 European Patent Office (UPC States) | EP 5,102,171 | European Counterpart (EP) | View Official Patent → |
| 🇺🇸 United States | US 66,449,705 P | US Continuation / Sibling | View Official Patent → |
| 🌐 PCT International (WIPO) | WO 2006097537 A2 | PCT World Application | View Official Patent → |
| 🇺🇸 United States | US 90,883,408 A | US Continuation / Sibling | View Official Patent → |